Clinical Trial

Oral Steroid Taper After Total Knee Arthroplasty

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the effectiveness of an oral methylprednisolone taper in reducing postoperative pain, opioid consumption, and nausea following primary total knee arthroplasty (TKA).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-09.
Status change: Recruiting → Active, Not Recruiting 2026-04-15
Trial Details
NCT Number NCT07070882
Lead Sponsor Columbia University
Conditions Osteoarthritis, Knee
Enrollment 116 participants
Start Date 2025-06-20
Primary Completion 2025-12-01 (estimated)
Study Completion 2027-06-20 (estimated)
Updated on ClinicalTrials.gov 2026-04-20